Literature DB >> 9661033

Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

C Tremblay1, C Gaudreau.   

Abstract

The susceptibilities of 59 Campylobacter fetus subsp. fetus isolates to eight antibiotics were studied by the agar dilution, E-test, and disk diffusion methods. None of the isolates were beta-lactamase producers. All were susceptible to ampicillin, gentamicin, imipenem, and meropenem as determined by the three methods, with MICs at which 90% of the isolates are inhibited (MIC90s) (determined by agar dilution) of 2, 1, < or = 0.06, and 0.12 microgram/ml, respectively. Twenty-seven percent of the isolates were resistant to tetracycline, with complete agreement between the agar dilution and disk diffusion results. The MIC90s determined by agar dilution were 2 micrograms/ml for erythromycin, 1 microgram/ml for ciprofloxacin, and 8 micrograms/ml for cefotaxime.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661033      PMCID: PMC105695     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli.

Authors:  C Gaudreau; H Gilbert
Journal:  J Antimicrob Chemother       Date:  1997-06       Impact factor: 5.790

Review 2.  Mechanisms of antibiotic resistance in Campylobacter species.

Authors:  D E Taylor; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.

Authors:  J P Butzler; P Dekeyser; T Lafontaine
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

4.  Relapsing septicemia caused by Campylobacter fetus subsp. fetus.

Authors:  J Righter; W A Wells; G D Hart; D J McNeely
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262

5.  Campylobacter fetus subspecies fetus bacteremia.

Authors:  P Francioli; J Herzstein; J P Grob; J J Vallotton; G Mombelli; M P Glauser
Journal:  Arch Intern Med       Date:  1985-02

6.  Biochemical and genetic characteristics of atypical Campylobacter fetus subsp. fetus strains isolated from humans in the United States.

Authors:  P Edmonds; C M Patton; T J Barrett; G K Morris; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.

Authors:  R M Fliegelman; R M Petrak; L J Goodman; J Segreti; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

8.  Characterization of tetracycline resistance plasmids from Campylobacter jejuni and Campylobacter coli.

Authors:  D E Taylor; R S Garner; B J Allan
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

9.  Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents.

Authors:  A W Chow; V Patten; D Bednorz
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

10.  Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

View more
  10 in total

1.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus.

Authors:  Carlos Abril; Isabelle Brodard; Vincent Perreten
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Infective abdominal aortitis due to Campylobacter fetus bacteremia: A case report and review of literature.

Authors:  Abhinav Agrawal; Rutuja R Sikachi
Journal:  Intractable Rare Dis Res       Date:  2016-11

4.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.

Authors:  Amera Gibreel; Veronica N Kos; Monika Keelan; Cathy A Trieber; Simon Levesque; Sophie Michaud; Diane E Taylor
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Campylobacter fetus bloodstream infection: risk factors and clinical features.

Authors:  L Gazaigne; P Legrand; B Renaud; B Bourra; E Taillandier; C Brun-Buisson; P Lesprit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-13       Impact factor: 3.267

Review 6.  A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.

Authors:  A Monselise; D Blickstein; I Ostfeld; R Segal; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-24       Impact factor: 3.267

7.  Campylobacter fetus meningitis in a diabetic adult cured by imipenem.

Authors:  J Herve; N Aissa; P Legrand; M Sorkine; M J Calmette; A Santin; E Roupie; B Renaud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-20       Impact factor: 3.267

8.  Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children.

Authors:  Roya Nikfar; Ahmad Shamsizadeh; Tahereh Ziaei Kajbaf; Mohammad Kamali Panah; Soheila Khaghani; Mina Moghddam
Journal:  Iran J Microbiol       Date:  2015-04

9.  Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle.

Authors:  Robert Escher; Colette Brunner; Niklaus von Steiger; Isabelle Brodard; Sara Droz; Carlos Abril; Peter Kuhnert
Journal:  BMC Infect Dis       Date:  2016-05-14       Impact factor: 3.090

10.  Campylobacter fetus bacteremia and meningitis in an acute lymphoblastic leukemia patient undergoing maintenance therapy: a case report.

Authors:  Ryo Nakatani; Koki Shimizu; Takahiro Matsuo; Ryosuke Koyamada; Nobuyoshi Mori; Takuya Yamashita; Shinichiro Mori
Journal:  BMC Infect Dis       Date:  2021-07-13       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.